Patient Capital Management 13F, Q3 2025

Samantha McLemore · quarter ending 30 September 2025 · filed 30 October 2025 · SEC CIK 1854794

$2.50B
Filed US book
41
Positions
6.0%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed.

Largest positions, Q3 2025

The 25 largest of 41 positions. Weights are against the whole filed book. Changes are in shares held, against the Q2 2025 filing.

CompanyTickerValue% of bookvs Q2 2025
ALPHABET INCGOOGL$149.10M6.0%unchanged
CITIGROUP INCC$133.01M5.3%-3% shares
UNITEDHEALTH GROUP INCUNH$128.23M5.1%+94% shares
QXO INCQXO$124.60M5.0%unchanged
AMAZON COM INCAMZN$123.39M4.9%unchanged
NVIDIA CORPORATIONNVDA$118.05M4.7%unchanged
NORWEGIAN CRUISE LINE HLDG L$112.43M4.5%-3% shares
ROYALTY PHARMA PLC$110.00M4.4%+4% shares
META PLATFORMS INCMETA$105.75M4.2%unchanged
CVS HEALTH CORPCVS$93.48M3.7%unchanged
ALIBABA GROUP HLDG LTDBABA$87.52M3.5%unchanged
PRECIGEN INCPGEN$87.06M3.5%+63% shares
ENERGY TRANSFER L PET$83.88M3.4%+20% shares
IAC INCPPLI$71.83M2.9%+21% shares
SEADRILL LTD$67.37M2.7%unchanged
UNITED AIRLS HLDGS INCUAL$64.32M2.6%unchanged
FIDELITY WISE ORIGIN BITCOINFBTC$61.86M2.5%unchanged
UBS GROUP AG$61.53M2.5%-23% shares
SOFI TECHNOLOGIES INCSOFI$59.55M2.4%-29% shares
COINBASE GLOBAL INCCOIN$57.96M2.3%-16% shares
GENERAL MTRS COGM$57.35M2.3%unchanged
BIOGEN INCBIIB$55.56M2.2%+24% shares
ILLUMINA INCILMN$55.21M2.2%unchanged
EXPEDIA GROUP INCEXPE$54.18M2.2%-3% shares
ONEMAIN HLDGS INCOMF$52.90M2.1%-9% shares

What changed since Q2 2025

Against the Q2 2025 filing, Patient Capital Management opened 2 new positions, added to 10, trimmed 11, left 18 unchanged and exited 1. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

Exited

Added to

  • UNH+94%$128.23M
  • ROYALTY PHARMA PLC+4%$110.00M
  • PGEN+63%$87.06M
  • ET+20%$83.88M
  • PPLI+21%$71.83M
  • BIIB+24%$55.56M
  • CROX+17%$49.19M
  • MAT+43%$35.33M

and 2 more

Trimmed

  • C-3%$133.01M
  • NORWEGIAN CRUISE LINE HLDG L-3%$112.43M
  • UBS GROUP AG-23%$61.53M
  • SOFI-29%$59.55M
  • COIN-16%$57.96M
  • EXPE-3%$54.18M
  • OMF-9%$52.90M
  • DAL-4%$48.88M

and 3 more

Other quarters

Source: SEC Form 13F-HR, accession 0001854794-25-000004, filed by Patient Capital Management, LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.